NCT00288236 - Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) | Biotech Hunter

Enrollment

368

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Rimonabant (SR141716)

DRUG

Placebo

Trial Locations (12)

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Buenos Aires

Sanofi-Aventis, Lane Cove

Sanofi-Aventis, Laval

Sanofi-Aventis, Providencia

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Milan

Sanofi-Aventis, Gouda

Sanofi-Aventis, Moscow

Sanofi-Aventis, Midrand

Sanofi-Aventis, Guildford